130 related articles for article (PubMed ID: 32148838)
1. Remarkable response to nivolumab in sarcomatoid malignant pleural mesothelioma with high PD-L1.
Tsubouchi K; Inoue S; Ibusuki R; Iwasaki T; Harada T
Respirol Case Rep; 2020 Apr; 8(3):e00536. PubMed ID: 32148838
[TBL] [Abstract][Full Text] [Related]
2. Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case series.
Hashimoto K; Ozasa H; Yoshizawa A; Yoshida H; Ogimoto T; Hosoya K; Yamazoe M; Ajimizu H; Funazo T; Yoshida H; Sakamori Y; Hirai T
Oncol Lett; 2022 Nov; 24(5):402. PubMed ID: 36276492
[TBL] [Abstract][Full Text] [Related]
3. Metastasis of Sarcomatoid Malignant Mesothelioma With
Chen KB; Huang YJ; Huang Y; Wu ZW; Jin XL; Zhang H; Xiang XP; Chen L; Chen L
Int J Surg Pathol; 2021 Dec; 29(8):856-863. PubMed ID: 33729861
[TBL] [Abstract][Full Text] [Related]
4. [Two cases of pulmonary sarcomatoid carcinoma mimicking malignant mesothelioma].
Inomata M; Kawagishi Y; Yamada T; Miwa T; Hayashi R; Kashii T; Matsui S; Fukuoka J; Tobe K
Nihon Kokyuki Gakkai Zasshi; 2010 Jan; 48(1):33-8. PubMed ID: 20163019
[TBL] [Abstract][Full Text] [Related]
5. Thoracic mesenchymal malignant tumors and programed cell death ligand-1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eight malignant mesotheliomas.
Otsubo K; Sakai H; Kimura H; Miyazawa T; Marushima H; Kojima K; Furuya N; Mineshita M; Chosokabe M; Koike J; Saji H
Thorac Cancer; 2021 Dec; 12(23):3169-3176. PubMed ID: 34655161
[TBL] [Abstract][Full Text] [Related]
6. Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement.
Bronte G; Delmonte A; Burgio MA; Verlicchi A; Puccetti M; Bravaccini S; Cravero P; Tumedei MM; Diano D; Rossi G; Ulivi P; Martinelli G; Crinò L
Lung Cancer; 2020 Apr; 142():47-50. PubMed ID: 32088605
[TBL] [Abstract][Full Text] [Related]
7. Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas.
Combaz-Lair C; Galateau-Sallé F; McLeer-Florin A; Le Stang N; David-Boudet L; Duruisseaux M; Ferretti GR; Brambilla E; Lebecque S; Lantuejoul S
Hum Pathol; 2016 Jun; 52():9-18. PubMed ID: 26980049
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report.
Tanaka T; Asakura S; Hisamatsu K; Fujimoto N
JTO Clin Res Rep; 2022 Jul; 3(7):100351. PubMed ID: 35795882
[TBL] [Abstract][Full Text] [Related]
9. Traditional Treatment Approaches and Role of Immunotherapy in Lung Malignancy and Mesothelioma.
Tamanna MT; Egbune C
Cancer Treat Res; 2023; 185():79-89. PubMed ID: 37306905
[TBL] [Abstract][Full Text] [Related]
10. Phrenic nerve paralysis as the initial presentation in pleural sarcomatoid mesothelioma.
Makimoto G; Fujiwara K; Fujimoto N; Yamadori I; Sato T; Kishimoto T
Case Rep Oncol; 2014 May; 7(2):389-92. PubMed ID: 25076889
[TBL] [Abstract][Full Text] [Related]
11. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F
Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216
[TBL] [Abstract][Full Text] [Related]
12. Deciduoid type malignant pleural mesothelioma: a case report.
Okita R; Nojima Y; Saisho S; Shimizu K; Shirai R; Kanomata N; Oka M; Nakata M
AME Case Rep; 2018; 2():43. PubMed ID: 30506035
[TBL] [Abstract][Full Text] [Related]
13. Alveolar-filling growth pattern of sarcomatoid malignant pleural mesothelioma.
Hayakawa T; Tajima S; Takanashi Y; Takahashi T; Neyatani H; Funai K
Respirol Case Rep; 2016 Sep; 4(5):e00175. PubMed ID: 27516891
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological characteristics and prognosis of malignant pleural mesothelioma].
Chen WH; Zhang XL; Dai HP; Tong ZH; Zhang YH; Jin ML
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):825-8. PubMed ID: 24507393
[TBL] [Abstract][Full Text] [Related]
15. Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
Scherpereel A; Mazieres J; Greillier L; Lantuejoul S; Dô P; Bylicki O; Monnet I; Corre R; Audigier-Valette C; Locatelli-Sanchez M; Molinier O; Guisier F; Urban T; Ligeza-Poisson C; Planchard D; Amour E; Morin F; Moro-Sibilot D; Zalcman G;
Lancet Oncol; 2019 Feb; 20(2):239-253. PubMed ID: 30660609
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin plus pemetrexed therapy and subsequent immune checkpoint inhibitor administration for malignant peritoneal mesothelioma without pleural lesions: Case report.
Ikushima H; Sakatani T; Ohara S; Takeshima H; Horiuchi H; Morikawa T; Usui K
Medicine (Baltimore); 2020 May; 99(22):e19956. PubMed ID: 32481365
[TBL] [Abstract][Full Text] [Related]
17. A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion.
Gu R; Jiang L; Duan T; Chen C; Wu S; Mu D
Onco Targets Ther; 2021; 14():4231-4237. PubMed ID: 34295165
[TBL] [Abstract][Full Text] [Related]
18. An Autopsied Case of Malignant Sarcomatoid Pleural Mesothelioma in Which Chest Pain Developed Several Months Earlier without Abnormality on Imaging.
Yaguchi D; Ichikawa M; Inoue N; Kobayashi D; Matsuura A; Shizu M; Imai N; Watanabe K
Case Rep Oncol; 2015; 8(3):439-46. PubMed ID: 26600776
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study.
Koda Y; Kuribayashi K; Doi H; Kitajima K; Nakajima Y; Ishigaki H; Nakamura A; Minami T; Takahashi R; Yokoi T; Kijima T
Oncology; 2021; 99(3):161-168. PubMed ID: 33053560
[TBL] [Abstract][Full Text] [Related]
20. [An autopsy case of sarcomatoid malignant mesothelioma mimicking adenocarcinoma with sarcomatoid elements of lung].
Tamiya M; Yamane H; Terada H; Matsuno O; Yamamoto S
Nihon Kokyuki Gakkai Zasshi; 2008 Nov; 46(11):904-8. PubMed ID: 19068764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
